StockData
Satellos Bioscience Inc. logo

Satellos Bioscience Inc. (MSLE) stock

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30
$5.94−0.26 (-4.19%)

Close on Nov 18, 2026Market cap $91.83MP/E –Yield –

Satellos Bioscience free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$23.60M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.60M–
FY2024Dec 31, 2024-$18.26M–

More Satellos Bioscience figures

See a number that looks wrong?